Skip to main content

Advertisement

Log in

No germline mutations in the dimerization domain of MXI1 in prostate cancer clusters

  • Experimental Oncology
  • Published:
British Journal of Cancer Submit manuscript

Abstract

There is evidence that predisposition to cancer has a genetic component. Genetic models have suggested that there is at least one highly penetrant gene predisposing to this disease. The oncogene MXI1 on chromosome band 10q24-25 is mutated in a proportion of prostate tumours and loss of heterozygosity occurs at this site, suggesting the location of a tumour suppressor in this region. To investigate the possibility that MXI1 may be involved in inherited susceptibility to prostate cancer, we have sequenced the HLH and ZIP regions of the gene in 38 families with either three cases of prostate cancer or two affected siblings both diagnosed below the age of 67 years. These are the areas within which mutations have been described in some sporadic prostate cancers. No mutations were found in these two important coding regions and we therefore conclude that MXI1 does not make a major contribution to prostate cancer susceptibility.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Consortia

Rights and permissions

Reprints and permissions

About this article

Cite this article

Edwards, S., Dearnaley, D., Ardern-Jones, A. et al. No germline mutations in the dimerization domain of MXI1 in prostate cancer clusters. Br J Cancer 76, 992–1000 (1997). https://doi.org/10.1038/bjc.1997.498

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/bjc.1997.498

  • Springer Nature Limited

Navigation